BROWSE·page 896 of 1501

Browse EX-10 agreements

18,005 total material contract exhibits.


EX-10.2

Kiniksa Pharmaceuticals International, plc

​

MASTER CONSULTING AGREEMENT

​

This Master Consulting Agreement (the “Agreement”) is made as of May 13, 2026 and will be effective on May 15, 2026 (the “Effective Date”) by and between Kiniksa Pharmaceuticals, GmbH, a Swiss limited liability company with a business address at Grafenaustrasse 5, 6300 Zug, Switzerland (“Kiniksa”), and Eben Tessari (“Consultant”).

​

WHEREAS, Consultant’s last day of employment with Kiniksa is May 15, 2026; and

​

WHEREAS, Kiniksa wants the continued benefit of Consultant's knowledge and expertise; and

​

WHEREAS, Consultant wants to provide Services (as defined below) to Kiniksa, its designees and affiliates, in connection with its global programs and operations, as provided in and subject to this Agreement;

​

NOW THEREFORE, in consideration of the premises and of the following mutual promises, covenants and conditions herein contained, and intending to be legally bound, Kiniksa and Consultant agree as follows:

​

…

EX-10.2·10-Q·CIK 1730430·ACC 0001104659-26-087545·Filed Jul 28, 2026, 16:17 ET

EX-10.1

Kiniksa Pharmaceuticals International, plc

​

EMPLOYMENT AGREEMENT

​

This Employment Agreement (this “Agreement”) is made and entered into as of June 29, 2026 (the “Effective Date”), by and between Kiniksa Pharmaceuticals Corp., a Delaware corporation (the “Company”), and Dhiraj Malkani (the “Employee”).

WHEREAS, the operations of the Company and its Affiliates (as defined below) are a complex matter requiring direction and leadership in a variety of arenas;  

WHEREAS, the Employee possesses certain experience and expertise that qualify the Employee to provide the direction and leadership required by the Company and its Affiliates; and

WHEREAS, the Company wishes to employ the Employee on the terms and conditions set forth in this Agreement, and the Employee wishes to be employed under such terms and conditions.

NOW, THEREFORE, in consideration of the foregoing premises and the mutual promises, terms, provisions and conditions set forth in this Agreement, the Company and the Employee hereby agree:

…

EX-10.1·10-Q·CIK 1730430·ACC 0001104659-26-087545·Filed Jul 28, 2026, 16:17 ET

EX-10.1

Element Solutions Inc

AMENDMENT TO ADVISORY SERVICES AGREEMENT

This AMENDMENT TO ADVISORY SERVICES AGREEMENT (this “Amendment”) is entered into and effective as of May 5, 2026 by and between Element Solutions Inc (the “Company”) and Mariposa Capital, LLC, a Delaware limited liability company (“Consultant”).

WHEREAS, the Company and Consultant are parties to that certain Advisory Services Agreement dated as of October 31, 2013 (as amended, supplemented or otherwise modified from time to time prior to the date hereof, the “Services Agreement”) pursuant to which the Company has received from Consultant, and Consultant has provided to the Company, the Services (as defined in the Services Agreement) pursuant to the terms and conditions set forth therein;

WHEREAS, each of the Company and Consultant desires to amend the Services Agreement as set forth herein; and

NOW, THEREFORE, in consideration of the mutual agreements hereinafter set forth, the parties hereto agree as follows:

1.Amendment of Section 1(c).

.

…

EX-10.1·10-Q·CIK 1590714·ACC 0001590714-26-000065·Filed Jul 28, 2026, 16:16 ET

EX-10.2

Element Solutions Inc

LETTER AGREEMENT

John,

This letter confirms that your Change in Control Agreement, dated as of November 6, 2019 (the “CIC Agreement”), with Element Solutions, Inc. (the “Company”) remains in full force and effect. In the event that the Agreement and Plan of Merger dated as of July 6, 2026 between the Company and Solstice Advanced Materials Inc. closes, then the Company agrees that (1) your resignation within 30 days after such closing will be treated as a resignation for Good Reason under the CIC Agreement1, (2) your incentive payment under Section 4 of the CIC Agreement will be $600,000 and (3) your termination payment under Sections 7(b) and (c) of the CIC Agreement will be $2,400,0002. All other provisions of the CIC Agreement will remain in effect pursuant to their terms.

Sincerely,

Element Solutions Inc

/s/ Benjamin Gliklich

Name: Benjamin Gliklich

Title: CEO

Date: July 6, 2026

Acknowledged and Agreed

/s/ John E. Capps

John E. Capps

Date: July 6, 2026

_____________________________________

…

EX-10.2·10-Q·CIK 1590714·ACC 0001590714-26-000065·Filed Jul 28, 2026, 16:16 ET

EX-10.1

Apple Hospitality REIT, Inc.

Published Deal CUSIP: 03785AAQ5

Published Revolver CUSIP: 03785AAR3

Published Term A-1 CUSIP: 03785AAS1

Published Term A-2 CUSIP: 03785AAT9

FOURTH AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of July 23, 2026

among

APPLE HOSPITALITY REIT, INC.,

as the Borrower,

CERTAIN SUBSIDIARIES OF APPLE HOSPITALITY REIT, INC.
FROM TIME TO TIME PARTY HERETO,
as Guarantors,

BANK OF AMERICA, N.A.,
as Administrative Agent,

WELLS FARGO BANK, NATIONAL ASSOCIATION,

KEYBANK NATIONAL ASSOCIATION and U.S. BANK NATIONAL ASSOCIATION,

as Co-Syndication Agents

PNC BANK, NATIONAL ASSOCIATION, andTRUIST BANK,

as Documentation Agents

BMO BANK, N.A. andREGIONS BANK,

as Managing Agents

and

The Lenders and L/C Issuers Party Hereto

BofA SECURITIES, INC.,

WELLS FARGO SECURITIES, LLC,
KEYBANC CAPITAL MARKETS,
U.S. BANK NATIONAL ASSOCIATION,
PNC CAPITAL MARKETS LLC,
and
TRUIST BANK,
as Joint Lead Arrangers

BofA SECURITIES, INC.,

WELLS FARGO SECURITIES, LLC,
KEYBANC CAPITAL MARKETS,
U.S. BANK NATIONAL ASSOCIATION,
as Joint Bookrunners


TABLE OF CONTENTS

SectionPage

…

EX-10.1·8-K·CIK 1418121·ACC 0001193125-26-321027·Filed Jul 28, 2026, 16:15 ET

EX-10.1

NXP Semiconductors N.V.

NXP Confidential Exhibit 10.1 NXP SEMICONDUCTORS N.V. 2019 OMNIBUS INCENTIVE PLAN JULY 2026 PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENT This Performance Restricted Stock Unit Award Agreement (this “PSU Agreement”) is made effective as of the date indicated in the grant summary in the Company’s equity recordkeeping system (the “Date of Grant”), by and between NXP Semiconductors N.V., a public limited liability company (naamloze vennootschap) organized under the Laws of The Netherlands (the “Company”), and the recipient of the grant (the “Participant”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the NXP Semiconductors N.V. 2019 Omnibus Incentive Plan (as may be amended from time to time, the “Plan”). 1. Grant of Performance Restricted Stock Units. The Company hereby grants to the Participant, subject to all of the terms and conditions of this PSU Agreement and the Plan, the number of performance restricted stock units (the “PSUs”) evidencing a right to receive a target number of shares of Common Stock as indicated in the grant summary

…

EX-10.1·10-Q·CIK 1413447·ACC 0001413447-26-000045·Filed Jul 28, 2026, 16:15 ET

EX-10.2

EchoStar CORP

EX-10·8-K·CIK 1415404·ACC 0001415404-26-000035·Filed Jul 28, 2026, 16:14 ET

EX-10.1

Qorvo, Inc.

QORVO, INC.

AMENDED AND RESTATED 2022 STOCK INCENTIVE PLAN

Restricted Stock Unit Agreement

(Performance-Based and Service-Based Retention Award)

THIS RESTRICTED STOCK UNIT AGREEMENT (together with Schedule A and Schedule B, attached hereto, the “Agreement”), is made effective as of June 4, 2026 (the “Effective Date”) between QORVO, INC., a Delaware corporation (the “Company”), and Philip Chesley, an Employee of, or individual in other service to, the Company or an Affiliate (the “Participant”). Any reference in this Agreement to the Company or any of its Affiliates shall be deemed to include any successor or surviving entity (or any parent thereof) in a Change in Control and their respective affiliates, and any reference to Shares shall be deemed to refer to the corresponding securities of such successor or surviving entity (or any parent thereof).

…

EX-10.1·10-Q·CIK 1604778·ACC 0001628280-26-050166·Filed Jul 28, 2026, 16:13 ET

EXHIBIT 10.1

Entera Bio Ltd.


Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 26, 2026, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each purchaser, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.1·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EXHIBIT 10.3

Entera Bio Ltd.


Exhibit 10.3

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 28, 2026, between Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of July 26, 2026, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agrees as follows:

1.             Definitions.

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the respective meanings given to such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section ‎6(b).

…

EX-10.3·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EXHIBIT 10.2

Entera Bio Ltd.


Exhibit 10.2

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT

ENTERA BIO LTD.

…

EX-10.2·8-K·CIK 1638097·ACC 0001178913-26-003617·Filed Jul 28, 2026, 16:12 ET

EX-10.1

Ranger Energy Services, Inc.

RANGER ENERGY SERVICES, INC.

AMENDED AND RESTATED 2017 LONG TERM INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT FOR DIRECTORS

Grant Date: [Grant Date] (the “Grant Date”)
Name of Grantee: [Participant Name] (the “Grantee” or “you”)
Number of Restricted Stock Units subject to Award: [Awards Granted] (the “RSUs”)

This Restricted Stock Unit Agreement (“Agreement”) is made and entered into as of the Grant Date by

and between Ranger Energy Services, Inc., a Delaware corporation (the “Company”), and you.

…

EX-10.1·10-Q·CIK 1699039·ACC 0001628280-26-050161·Filed Jul 28, 2026, 16:10 ET